Drug firms unveil price cuts | News | Al Jazeera

Drug firms unveil price cuts

Aid agencies welcome move to make life-saving drugs cheaper in the developing world, with caveats.

    A number of leading drug firms have announced plans to cut prices dramatically for life-saving drugs in the developing world.

    UK-based Glaxo Smithkline, says it will reduce the cost of its Rotarix vaccine by 67 per cent. It will now cost $5 to immunise a child against rotavirus, a leading cause of diarrhoea.

    The price cuts have been broadly welcomed by aid agencies. But Save the Children says it only goes partly in plugging a $3.7bn shortfall needed to produce life-saving drugs.

    Al Jazeera spoke to Paul Cook, the head of advocacy at Tearfund.

    SOURCE: Al Jazeera


    YOU MIGHT ALSO LIKE

    Interactive: Coding like a girl

    Interactive: Coding like a girl

    What obstacles do young women in technology have to overcome to achieve their dreams? Play this retro game to find out.

    America's Guns: Secret Pipeline to Syria

    America's Guns: Secret Pipeline to Syria

    How has the international arms trade exacerbated conflict in the Middle East? People and Power investigates.

    I remember the day … I designed the Nigerian flag

    I remember the day … I designed the Nigerian flag

    In 1959, a year before Nigeria's independence, a 23-year-old student helped colour the country's identity.